MedPath

RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy

Phase 4
Completed
Conditions
Epilepsy
Registration Number
NCT00564915
Lead Sponsor
Institute of Child Health
Brief Summary

A study of the efficacy and tolerability of two different ketogenic diets in children with drug resistant epilepsy; children resistant to at least two drugs randomised to reveive diet after baseline or after further 3m control period; in addition randomised to either MCT or classical ketogenic diet.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
145
Inclusion Criteria
  • Diagnosis of epilepsy for at least 2 years, resistant to at least two AEDs, at least 7 seizures/week
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change in seizure frequency3 months
Secondary Outcome Measures
NameTimeMethod
Tolerability and assessment of ketosis and growth3 months

Trial Locations

Locations (1)

Institute of Child Health, The Wolfson Centre

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath